| Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge K Tomczak, P Czerwińska, M Wiznerowicz Contemporary Oncology/Współczesna Onkologia 2015 (1), 68-77, 2015 | 4294 | 2015 |
| Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing SAM Abhijeet P. Deshmukh, Suhas V. Vasaikar, Katarzyna Tomczak, Shubham ... PNAS, 2021 | 208* | 2021 |
| Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ... Nature communications 12 (1), 6071, 2021 | 91 | 2021 |
| TRIM28 and interacting KRAB-ZNFs control self-renewal of human pluripotent stem cells through epigenetic repression of pro-differentiation genes U Oleksiewicz, M Gładych, AT Raman, H Heyn, E Mereu, ... Stem cell reports 9 (6), 2065-2080, 2017 | 87 | 2017 |
| TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development P Czerwińska, PK Shah, K Tomczak, M Klimczak, S Mazurek, B Sozańska, ... Oncotarget 8 (1), 863, 2016 | 64 | 2016 |
| Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ... Nature communications 13 (1), 2801, 2022 | 42 | 2022 |
| Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer E Orouji, AT Raman, AK Singh, A Sorokin, E Arslan, AK Ghosh, J Schulz, ... Gut 71 (5), 938-949, 2022 | 39 | 2022 |
| Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy CJ Terranova, M Tang, M Maitituoheti, AT Raman, AK Ghosh, J Schulz, ... Cell reports 36 (3), 2021 | 25 | 2021 |
| Contemp Oncol (Pozn). 2015; 19 (1A): A68 K Tomczak, P Czerwinska, M Wiznerowicz A77, 0 | 25 | |
| Dysregulation and epigenetic reprogramming of NRF2 signaling axis promote acquisition of cisplatin resistance and metastasis in head and neck squamous cell carcinoma AA Osman, E Arslan, M Bartels, C Michikawa, A Lindemann, K Tomczak, ... Clinical Cancer Research 29 (7), 1344-1359, 2023 | 21 | 2023 |
| Next-generation immunotherapies to improve anticancer immunity Y Shi, K Tomczak, J Li, JK Ochieng, Y Lee, C Haymaker Frontiers in pharmacology 11, 566401, 2021 | 21 | 2021 |
| Immune landscape of a genetically engineered murine model of glioma compared with human glioma DB Zamler, T Shingu, LM Kahn, K Huntoon, C Kassab, M Ott, K Tomczak, ... JCI insight 7 (12), 2022 | 15 | 2022 |
| Genomic correlates of outcome in tumor-infiltrating lymphocyte therapy for metastatic Melanoma CA Creasy, YJ Meng, MA Forget, T Karpinets, K Tomczak, C Stewart, ... Clinical Cancer Research 28 (9), 1911-1924, 2022 | 6 | 2022 |
| Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance H Fan, F Wang, A Zeng, A Murison, K Tomczak, D Hao, FZ Jelloul, ... Communications Biology 6 (1), 765, 2023 | 4 | 2023 |
| Review computational characterisation of cancer molecular profiles derived using next generation sequencing U Oleksiewicz, K Tomczak, J Woropaj, M Markowska, P Stępniak, ... Contemporary Oncology/Współczesna Onkologia 2015 (1), 78-91, 2015 | 4 | 2015 |
| Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival N Zhou, CS Bell, HA Feldman, CL Haymaker, WL Hofstetter, AS Tsao, ... The Journal of Thoracic and Cardiovascular Surgery 166 (2), 362-371. e9, 2023 | 3 | 2023 |
| Bivalent and broad chromatin domains regulate pro-metastatic drivers in melanoma C Terranova, M Tang, M Maitituoheti, AT Raman, J Schulz, SB Amin, ... bioRxiv, 721480, 2019 | 3 | 2019 |
| Single-cell characterization of acute myeloid leukemia (AML) and its microenvironment identifies signatures of resistance to PD-1 blockade based therapy HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ... Blood 136, 29-31, 2020 | 2 | 2020 |
| Single-cell characterization of acute myeloid leukemia and its microenvironment following PD-1 blockade based therapy HA Abbas, D Hao, K Tomczak, P Barrodia, JS Im, PK Reville, Z Alaniz, ... Biorxiv, 2020.09. 03.278309, 2020 | 2 | 2020 |
| 1448 Comparison of spatial transcriptomic platforms in FFPE TMA samples NO Lermi, M Molina, SD Hernandez, A Serrano, K Tomczak, W Lu, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | 1 | 2024 |
